Fruquintinib plus sintilimab significantly improved PFS in advanced RCC patients compared to axitinib or everolimus, with a median PFS of 22.21 months versus 6.90 months. The combination therapy ...

Get to know human resources specialist Paychex a little better and why the stock is a great choice for investors.

Brian Kelly and the LSU Tigers will take the field at FirstBank Stadium on Saturday with a matchup against No. 17 Vanderbilt ...

The world’s largest network of environmental groups approved the exploration of genetic engineering tools to aid the ...

Politics and real estate have long been intertwined, but seldom as directly as in the choices that voters face in the ballot ...